Name: NRx Pharmaceuticals, Inc. (NRXP) Balance Sheet
Creator: FinSpry

NRx Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for NRx Pharmaceuticals, Inc. (NRXP) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	1.44	4.60	20.05	27.61	1.86
Cash & Short-Term Investments	1.44	4.60	20.05	27.61	1.86
Accounts Receivable	0.00	0.01	0.01	0.00	0.83
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.86	1.41	3.77	4.60	0.21
Total Current Assets	3.30	6.88	25.80	32.71	2.93
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.35	0.43	0.02	0.02	0.01
Total Non-Current Assets	0.35	0.43	0.02	0.02	0.00
Total Assets	3.65	7.32	25.82	32.73	2.94
Current Liabilities
Accounts Payable	4.13	4.63	2.08	3.69	3.15
Short-Term Debt	1.57	9.16	7.70	0.52	0.25
Current Portion of Long-Term Debt	1.25	9.16	7.70	0.52	0.25
Accrued Liabilities	5.24	4.40	5.77	2.84	3.28
Other Current Liabilities	5.64	0.02	0.04	4.87	39.49
Total Current Liabilities	21.86	19.05	15.59	11.92	46.16
Non-Current Liabilities
Long-Term Debt	5.01	0.00	2.82	0.00	0.55
Other Non-Current Liabilities	0.00	0.00	0.91	0.00	0.00
Total Non-Current Liabilities	5.01	0.00	2.82	0.00	0.00
Total Liabilities	26.87	19.05	18.41	11.92	46.71
Stockholders' Equity
Common Stock	0.02	0.01	0.07	0.06	0.04
Retained Earnings	-278.27	-253.15	-223.00	-183.24	-90.18
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00
Additional Paid-in Capital	255.04	241.41	230.34	203.99	0.00
Shares Outstanding	14.59	8.39	6.64	5.88	0.00
Total Stockholders' Equity	-23.22	-11.73	7.41	20.81	-43.77
Total Liabilities & Equity	3.65	7.32	25.82	32.73	0.00